Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
  1. 4 Open-market sale EVP & Chief Strategy Officer sold 2,500 shares at $20.00 ($50,000)
  2. 4 Open-market sale EVP & Chief Financial Officer sold 24,000 shares at $20.00 ($480,000)
  3. 4 Open-market sale EVP & Chief Financial Officer sold 9,000 shares at $15.14 ($136,260)
  4. 4 Open-market sale Director sold 1,183 shares at $16.10 ($19,046)
  5. 4 Exercise or conversion EVP & Chief Financial Officer acquired 10,501 shares (option exercise)
  6. 4 Exercise or conversion Director acquired 1,603 shares (option exercise)
  7. 4 Open-market sale EVP & Chief Strategy Officer sold 14,273 shares at an average $15.42 ($220,144)
  8. 4 Open-market sale EVP & Chief R & QA Officer sold 3,059 shares at $15.96 ($48,822)
  9. 4 Open-market sale EVP, R&D & Chief Scientific Of sold 7,604 shares at $15.49 ($117,786)
  10. 4 Open-market sale Chief Executive Officer sold 4,800 shares at an average $15.56 ($74,664)
  11. 4 Open-market sale EVP & Chief Strategy Officer sold 6,274 shares at an average $15.47 ($97,029)
  12. 4 Open-market sale EVP, R&D & Chief Scientific Of sold 13,975 shares at $15.46 ($216,054)
  13. 4 Open-market sale EVP, General Counsel & Sec. sold 12,215 shares at an average $15.72 ($192,067)
  14. 4 Grant or award EVP, R&D & Chief Scientific Of acquired 49,500 shares (grant or award)
  15. 4 Grant or award EVP & Chief Financial Officer acquired 49,500 shares (grant or award)
  16. 4 Grant or award EVP & Chief Strategy Officer acquired 45,000 shares (grant or award)
  17. 4 Grant or award EVP, General Counsel & Sec. acquired 49,500 shares (grant or award)
  18. 4 Grant or award Chief Executive Officer acquired 165,000 shares (grant or award)
  19. 4 Grant or award EVP & Chief R & QA Officer acquired 49,500 shares (grant or award)
  20. 4 Open-market sale Chief Executive Officer sold 4,800 shares at an average $13.66 ($65,568)

Page 23 of 33 · 645 filings